-
Product Insights
NewDigital Pharm Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Digital Pharm Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Digital Pharm specializes in digital treatment devices and electronic drugs. Digital Pharm is headquartered in South Korea. GlobalData's Medical Devices company profile report, “Digital Pharm Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information and data related to: Top level information about the company...
-
Innovation Ranking
Innovation Ranking – Pharming Group NV
Pharming Group NV (Pharming) develops precision medicines and innovative protein replacement therapies for the treatment of rare diseases and unmet medical needs. The company’s marketed product includes, Ruconest (conestat alfa), a recombinant human C1 inhibitor is used for the treatment of acute hereditary angioedema (HAE) and has been approved in the US, the UK, Europe, Israel, and South Korea. Its product pipeline consists of leniolisib for treatment of activated phosphoinositide 3-kinase delta syndrome (APDS); α-Glucosidase for the treatment of Pompe...
-
Innovation Ranking
Innovation Ranking – Shin Poong Pharm Co Ltd
Shin Poong Pharm Co Ltd (Shin Poong) is a pharmaceutical company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. Its product portfolio includes over-the-counter, cephalosporin, penicillin, gentrisone cream, tolvaptan, mosapride citrate, medical devices, pyramax, irbesartan, and praziquantel. Shin Poong develops medicines in tablets, capsules, injections, syrups, ampoules, and creams. The company manufactures products for treating malaria, cardiovascular, and bone-related diseases. It operates in Gyeonggi-do, Ansan-si, Banweol and Chungbuk-do, South Korea. Shin Poong is headquartered in Seoul, South Korea.
-
Product Insights
NewSinsin Pharmaceutical Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Sinsin Pharmaceutical Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Sinsin Pharmaceutical Co Ltd (Sinsin Pharm) is a developer and manufacturer of medical plasters and sanitary aids. The company’s products include pain treatment patches, pain relief sprays, pain relief lotion and cream, hot patches, insect bite products, mosquito repellent, corn removal patches, dandruff removing liniment, cooling pads, head lice removing liniment and wound protection bands among others. Its...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Cilostazol + Rosuvastatin) in Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Cilostazol + Rosuvastatin) in Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Cilostazol + Rosuvastatin)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – UI-014 in Endocrine Gland Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - UI-014 in Endocrine Gland Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. UI-014 in Endocrine Gland Disorders Drug Details: UI-014 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Basroparib in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Basroparib in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Basroparib in Colorectal Cancer Drug Details: STP-061002 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Basroparib in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Basroparib in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Basroparib in Gastric Cancer Drug Details: STP-061002 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Basroparib in Hepatocellular Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Basroparib in Hepatocellular Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Basroparib in Hepatocellular Carcinoma Drug Details: STP-061002 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pirmitegravir in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pirmitegravir in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pirmitegravir in Human Immunodeficiency Virus (HIV) Infections...